Page 2 - Vivos Method News Today

-- Vivos Therapeutics said Wednesday the Food and Drug Administration has granted 510 clearance for its oral device treatment for severe obstructive sleep apnea in adults. The clearance is for its...

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Bioventus (NYSE:BVS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, earnings, risk, valuation, analyst recommendations, profitability and institutional ownership. Profitability This table compares Vivos Therapeutics and Bioventus’ […]

Vivos reported a decrease in Q3 revenue, juxtaposed against its efforts to expand internationally in the sleep treatment market.

Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) and Silk Road Medical (NASDAQ:SILK – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Valuation and Earnings This table compares […]

Vivos Therapeutics, Inc. (NASDAQ:VVOS – Get Free Report) saw a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 2,270,000 shares, an increase of 297.1% from the September 30th total of 571,600 shares. Based on an average daily trading volume, of 5,960,000 shares, the short-interest […]

LITTLETON, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (the "Company" or "Vivos") (NASDAQ:VVOS a leading medical technology company focused on developing innovative treatments for patients

Better sleep is better health, period. But for many people, it’s not that easy. Innovative medical technology company Vivos Therapeutics (NASDAQ:VVOS) is...

Shares of Vivos Therapeutics, Inc. (NASDAQ: VVOS) saw an extraordinary leap of over 60% October 4th, 2023. According to their latest release, they just released two important strategic agreements. With the company trading at such a low valuation and under NASDAQ's minimum bid compliance, the real question is whether or not these agreements will be

-- Health care stocks were lower Wednesday afternoon, with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund 0.2% softer. The iShares Biotechnology ETF was...

Vivos Executes Distribution Agreement with Established Dubai-based Sleep Testing CompanySubject to Regulatory Approvals, Vivos Could See Revenue F...